Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||- / 1||- / -|
Administered by: Unknown Purchased by: ??
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Diagnostic Lab Data:
CDC 'Split Type': USPFIZER INC2021659160
Write-up: She experienced migraine; This is a spontaneous report from a contactable consumer (patient) via a Pfizer sponsored program. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection), via an unspecified route of administration on 04Jun2021 as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that she received the 1st dose of Pfizer COVID- 19 vaccine yesterday and she experienced migraine that was yesterday on 04Jun2021 and this morning and she drank acetaminophen (NDC number, UPC number and Expiry Date of acetaminophen were unknown) as treatment and now she was asking if she can drink Butalbital 335 mg? It was reported that she was still experiencing Migraine. The outcome of the event was not recovered. Information on Lot/Batch number has been requested.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166